Fundraising Fox
Sentynl
1 known investors
Find your way into Sentynl
Sign up to see every warm intro you have to Sentynl
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sentynl team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.
Founders & leadership
MH
Matt HeckFounder & CEOHe previously co-founded Victory Pharmaceuticals where he served as CEO, was VP of Sales at DJ Pharma (which was acquired by Biovail), and held commercial roles at Dura Pharmaceuticals and Dial Corporation; he holds a Bachelor of Arts in marketing from the University of South Carolina.
Investors · 1
Frequently asked questions
- What does Sentynl do?
- A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.
- Who founded Sentynl?
- Sentynl was founded by Matt Heck.
- Who are Sentynl's investors?
- Sentynl's investors include Avego BioScience Capital.